Cited by 198Ethics in Clinical ResearchResearch Data Management PracticesHealth and Medical Research Impacts

Characterizing biobank organizations in the U.S.: results from a national survey

Open access
Henderson, Gail E, Cadigan, R Jean, Edwards, Teresa P, Conlon, Ian, Nelson, Anders G, Evans, James P, Davis, Arlene M, Zimmer, Catherine +1 more·2013·Genome Medicine

Abstract

Background: Effective translational biomedical research hinges on the operation of 'biobanks,' repositories that assemble, store, and manage collections of human specimens and related data. Some are established intentionally to address particular research needs; many, however, have arisen opportunistically, in a variety of settings and with a variety of expectations regarding their functions and longevity. Despite their rising prominence, little is known about how biobanks are organized and function beyond simple classification systems (government, academia, industry). Methods: In 2012, we conducted the first national survey of biobanks in the U.S., collecting information on their origins, specimen collections, organizational structures, and market contexts and sustainability. From a list of 636 biobanks assembled through a multi-faceted search strategy, representatives from 456 U.S. biobanks were successfully recruited for a 30-minute online survey (72% response rate). Both closed and open-ended responses were analyzed using descriptive statistics. Results: While nearly two-thirds of biobanks were established within the last decade, 17% have been in existence for over 20 years. Fifty-three percent listed research on a particular disease as the most important reason for establishment; 29% listed research generally. Other reasons included response to a grant or gift, and intent to centralize, integrate, or harmonize existing research structures. Biobank collections are extraordinarily diverse in number and types of specimens and in sources (often multiple) from which they are obtained, including from individuals, clinics or hospitals, public health programs, and research studies. Forty-four percent of biobanks store pediatric specimens, and 36% include postmortem specimens. Most biobanks are affiliated in one or multiple ways with other entities: 88% are part of at least one or more larger organizations (67% of these are academic, 23% hospitals, 13% research institutes). The majority of biobanks seem to fill a particular 'niche' within a larger organization or research area; a minority are concerned about competition for services, although many are worried about underutilization of specimens and long-term funding. Conclusions: Effective utilization of biobank collections and effective policies to govern their use will require understanding of the immense diversity found in organizational features, including the very different history and primary goals that many biobanks have.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/gm407

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Actual practice of informed consent for biospecimen research varies, as collections of biospecimens (or biobanks) are highly heterogeneous in terms of tissue type, procurement situation, and geographic, social, and historical context.

    “Actual practice varies, as collections of biospecimens (or biobanks) are highly heterogeneous in terms of tissue type, procurement situation, and geographic, social, and historical context (56, 58,60, 126, 146).”

    From Lessons from HeLa Cells: The Ethics and Policy of Biospecimens (2016) · cites this paper as [56]

    The Results and discussion (Specimen collections; page not specified) document variation in specimen types and how biobanks acquire them. The Conclusions (page not specified) connect that diversity to questions about consent and governance, but do not establish that actual informed-consent practices vary or document heterogeneity specifically by geographic, social, and historical context. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Biobanks or other repositories or databases used in their study have commercial interests that might influence research integrity.

    “Authors should disclose funding sources for biobanks or other repositories or databases used in their study because these entities also have commercial interests that might influence research integrity.124 125”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 55 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Henderson, G. E., Cadigan, R. J., Edwards, T. P., Conlon, I., Nelson, A. G., Evans, J. P., Davis, A. M., Zimmer, C., & Weiner, B. J.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
Henderson, Gail E
Venue
Genome Medicine
Published
2013-01-25
Volume
5
Issue
1
Pages
3-3
ISSN
1756-994X (ISSN-L)
OpenAlex
W2168218485
Cited by
198
References
55
Citations by year
2026: 9 · 2025: 7 · 2024: 5 · 2023: 7 · 2022: 12 · 2021: 19 · 2020: 8 · 2019: 11 · 2018: 13 · 2017: 19 · 2016: 27 · 2015: 23 · 2014: 23 · 2013: 15
FWCI
30.00
Type
journal article
Language
en
Open access
Locations
  • Genome Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, cc-by)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • Georgia Clinical and Translational Science Alliance
  • National Human Genome Research Institute (P50HG004488, HG004488)
  • National Center for Research Resources (UL1RR025747)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health and Medical Research Impacts
Keywords
biobanks, biobank sustainability, biobank governance, postmortem specimens, translational research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review